Piper Sandler Reiterates Overweight on Omnicell, Lowers Price Target to $45
Omnicell, Inc.
Omnicell, Inc. OMCL | 0.00 |
Piper Sandler analyst Jessica Tassan reiterates Omnicell (NASDAQ:
OMCL) with a Overweight and lowers the price target from $55 to $45.